While hospitalized, a blood test showed that the patient had, chronic myeloproliferative neoplasm due to essential thrombocythemia with heterozygous positive JAK. The patient is currently receiving oral anticoagulation with warfarin and is being followed up as an outpatient.
Y actualmente recibe anticoagulación oral con warfarina y acude periódicamente a revisiones de control ambulatorio en nuestro servicio.